Back to results
US 7,083,969 B2Granted
Serratia marcescens strain
AssigneeKorea Research Institute of Bioscience and Biotechnology
InventorsHwanmook Kim, Youngkook Kim, Sangbae Han, Sungrak Yoo
Life of this patent
Estimating the term…
Abstract
There are disclosed a novel microorganism Serratia marcescens strain and a prodigiosin isolated from the microorganism. The prodigiosin is useful as an immunosuppressive in various fields, including the treatment of the diseases requiring immunosuppression and the basic research for the diseases, the transplantation of the organs or tissues, and the immune cells.
Claims1
A biologically pure culture of Serratia marcescens B-1231, KCTC 0386BP.
Dependencies are inferred from the claim text.